Innovative Solutions, Expert Support, and Transparent Practices
EvidentIQ Group provides specialized eClinical software for organisations in the clinical research sector. Our solutions include Electronic Data Capture, eCOA, ePRO, eTMF, and clinical trial management systems. We complement our software by data science capabilities, patient recruitment services, and real-world evidence solutions. Together, these offerings support controlled, data-driven execution of clinical trials across their full operational scope.
The EvidentIQ Group is a leading provider of modern eClinical solutions designed specifically for experts in clinical research.
Our focus continues to remain on improving clinical trial execution by prioritizing four core performance parameters: time, quality, cost, and flexibility. These principles guide the design and operation of our platforms to support efficient, reliable, and scalable clinical research.
Accelerating Your Path to Successful Trials
Maximizing Value with 0 Compromises
Delivering Excellence at Every Step
Customisation and Scalability
1997
Fortress Medical System (FMS) was founded in Minnesota, USA.
FMS launched its solution Clindex
2002
XClinical was founded in Munich, Germany.
XClinical launched its solution Marvin EDC.
2006
Dacima Software was founded in Montréal, Canada.
Dacima Software launched its solutions Dacima EDC.
2019
Dacima designs a registry database for the world’s largest prostate cancer patient network with Movember, integrating real-world data from over 130,000 men globally.
2020
Marvin, Carenity and Fortress Medical System merge to one company.
2021
The EvidentIQ Group is founded. Marvin, Clindex, and Carenity officially join as brands. Carenity’s PatientLive® solution launches, connecting 500,000 patients and caregivers worldwide.
2022
Dacima EDC becomes the third brand in the EvidentIQ group.Dacima EDC becomes the third brand in the EvidentIQ group.
2023
Asthenis the expert for tumor documentation are joining EvidentIQ Group.
2024
2026
EvidentIQ completes a strategic transaction with AB Cube, reinforcing its focus on Dacima, Clindex, and Carenity to drive innovation and patient-centric clinical technology.